Baby Steps New work shows the promise, and pitfalls, of embryonic-stem-cell research

A Happy Pill for Some Biotechs Analysts predict 2003’s rally will continue, with the winners changing to include a few

Biotech: A Coming Boom — or Bust? Two industry veterans lay out contrasting views about what the sector and its

Biotech may be poised for “big year” Biotechnology is poised for a boom year in 2004, wrapping up 2003 with

Biotech may be poised for “big year” Biotechnology is poised for a boom year in 2004, wrapping up 2003 with

Got Life? Corporate lawyers haven’t had much to celebrate since the Internet bubble burst, but a recent stock market run

When Patents Persist What if that patent you’re paying royalties on suddenly gets extended? Have you negotiated the best licensing

Amgen’s Cannibalistic Ways If you don’t think that Amgen is excited about its future, check out what the company is

Amgen’s Cannibalistic Ways If you don’t think that Amgen is excited about its future, check out what the company is

FDA Chief Eyes Path for Copycat Biotech Drugs Food and Drug Administration Commissioner Mark McClellan said on Friday it may